[{"AccountsPayableCurrent_0_Q2_USD":11005000.0,"PaymentsToAcquireInvestments_2_Q2_USD":329379000.0,"PaymentsToAcquireEquityMethodInvestments_2_Q2_USD":15938000.0,"PaymentsForProceedsFromTenantAllowance_2_Q2_USD":1111000.0,"PaymentsForLeasingCostsCommissionsAndTenantImprovements_2_Q2_USD":2432000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1135000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":624000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":5705000.0,"OtherExpenses_2_Q2_USD":856000.0,"OtherExpenses_1_Q2_USD":531000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-602000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-233000.0,"OtherAssetsNoncurrent_0_Q2_USD":5829000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0842,"OperatingLeaseRightOfUseAsset_0_Q2_USD":39474000.0,"OperatingLeasePayments_2_Q2_USD":2400000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":51209000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3147000.0,"OperatingLeaseLiability_0_Q2_USD":54356000.0,"OperatingLeaseExpense_2_Q2_USD":2394000.0,"OperatingLeaseCost_2_Q2_USD":3715000.0,"OperatingLeaseCost_1_Q2_USD":1853000.0,"OperatingIncomeLoss_2_Q2_USD":-104230000.0,"OperatingIncomeLoss_1_Q2_USD":-71029000.0,"OperatingExpenses_2_Q2_USD":142619000.0,"OperatingExpenses_1_Q2_USD":71073000.0,"NonoperatingIncomeExpense_2_Q2_USD":279000.0,"NonoperatingIncomeExpense_1_Q2_USD":93000.0,"NetIncomeLoss_2_Q2_USD":-103951000.0,"NetIncomeLoss_1_Q2_USD":-70936000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":17363000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-90498000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockSharesIssued_0_Q2_shares":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":133503262.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":134826805.0,"VariableLeaseCost_2_Q2_USD":531000.0,"VariableLeaseCost_1_Q2_USD":204000.0,"TenantImprovements_0_Q2_USD":5000000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":7274000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3214000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":1984000.0,"StockholdersEquity_0_Q2_USD":1023812000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_Q2_USD":1564000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q2_USD":854000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensation_2_Q2_USD":37926000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":38389000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":44000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-750294000.0,"RestrictedCashNoncurrent_0_Q2_USD":9449000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":107473000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":52290000.0,"PurchaseCommitmentRemainingMinimumAmountCommitted_0_Q2_USD":4200000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":125459000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":142249000.0,"ProfitLoss_2_Q2_USD":-103951000.0,"ProceedsFromStockPlans_2_Q2_USD":1984000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":484082000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":7274000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":14464000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":134826805.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":121392000.0,"LiabilitiesCurrent_0_Q2_USD":45998000.0,"CommonStockValue_0_Q2_USD":142000.0,"CommonStockSharesOutstanding_0_Q2_shares":142120731.0,"CommonStockSharesIssued_0_Q2_shares":142120731.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":17204935.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CashEquivalentsAtCarryingValue_0_Q2_USD":169728000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":40152000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":232952000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":913200000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":223503000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1706000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":325523000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":364204000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":859346000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":227000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":336000.0,"AssetsCurrent_0_Q2_USD":602171000.0,"Assets_0_Q2_USD":1126724000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":19673348.0,"AmortizationOfIntangibleAssets_2_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":37926000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":21134000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":21134000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":37926000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1774298000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-334000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":16790000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-71169000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":9258000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-104553000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1126724000.0,"Liabilities_0_Q2_USD":102912000.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":5200000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":30057000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":3570000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":8168000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":8430000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":8509000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":7917000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":84737000.0,"LeaseCost_2_Q2_USD":4246000.0,"LeaseCost_1_Q2_USD":2057000.0,"InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0_Q2_USD":18819000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-3746000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-2755000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":2622000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":660000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-38687000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-2470000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1088000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":35146000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":18783000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.78,"EarningsPerShareDiluted_1_Q2_USD":-0.53,"EarningsPerShareBasic_2_Q2_USD":-0.78,"EarningsPerShareBasic_1_Q2_USD":-0.53,"Depreciation_2_Q2_USD":3882000.0,"DeferredCompensationShareBasedArrangementsLiabilityCurrent_0_Q2_USD":4300000.0,"DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent_0_Q2_USD":3400000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":305000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":133503262.0,"Ticker":"ALLO","CIK":"1737287","name":"ALLOGENE THERAPEUTICS, INC.","OfficialName":"Allogene Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1134878416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]